載入中
MindWalk Holdings Corp. functions as an innovative bio-native artificial intelligence firm. Its core mission involves leveraging the synergy of AI, comprehensive multi-omics data, and sophisticated laboratory investigations to accelerate the identification and advancement of biological therapeutics. Utilizing its proprietary LensAI platform and HYFT technology, the company forges partnerships with pharmaceutical and biotechnology enterprises. These collaborations are designed to diminish the inherent risks associated with drug development and to unlock new possibilities for treatments. Founded in 1983, the company adopted its current name, MindWalk Holdings Corp., in September 2025, having previously been known as ImmunoPrecise Antibodies Ltd. Its corporate headquarters are located in Austin, Texas.
前收盤價
US$1.40
−US$0.095 · -6.35%
盤後
US$1.43
+US$0.03 · +2.14%
10月12日 下午7:30 ET
盤中時間採用ET。市場資料可能有所延遲。
MindWalk Holdings Corp. functions as an innovative bio-native artificial intelligence firm. Its core mission involves leveraging the synergy of AI, comprehensive multi-omics data, and sophisticated laboratory investigations to accelerate the identification and advancement of biological therapeutics. Utilizing its proprietary LensAI platform and HYFT technology, the company forges partnerships with pharmaceutical and biotechnology enterprises. These collaborations are designed to diminish the inherent risks associated with drug development and to unlock new possibilities for treatments. Founded in 1983, the company adopted its current name, MindWalk Holdings Corp., in September 2025, having previously been known as ImmunoPrecise Antibodies Ltd. Its corporate headquarters are located in Austin, Texas.
日內區間
目前US$1.40
52週區間
目前US$1.40
盤中時間採用ET。市場資料可能有所延遲。
GoAI 評分
賣出
估值
52
合理估值
情緒
58
多空交錯
風險
70
高風險
動能
31
動能減弱
完整 GoAI 研究
繼續查看更深入的依據、催化因素和風險。
MindWalk Holdings Corp. functions as an innovative bio-native artificial intelligence firm. Its core mission involves leveraging the synergy of AI, comprehensive multi-omics data, and sophisticated laboratory investigations to accelerate the identification and advancement of biological therapeutics. Utilizing its proprietary LensAI platform and HYFT technology, the company forges partnerships with pharmaceutical and biotechnology enterprises. These collaborations are designed to diminish the inherent risks associated with drug development and to unlock new possibilities for treatments. Founded in 1983, the company adopted its current name, MindWalk Holdings Corp., in September 2025, having previously been known as ImmunoPrecise Antibodies Ltd. Its corporate headquarters are located in Austin, Texas.
日內區間
目前US$1.40
52週區間
目前US$1.40
獲利能力占已公布營收的百分比。
營收
營業利益
淨利
| 項目（CAD） | 2026會計年度 | 2025會計年度 | 2024會計年度 | 2023會計年度 | 2022會計年度 |
|---|---|---|---|---|---|
| 營收 | 1531.94萬 CAD | 2452萬 CAD | 2451.8萬 CAD | 2066.5萬 CAD | 1936.4萬 CAD |
| 銷貨成本 | 631.17萬 CAD | 1097.2萬 CAD | 1246.5萬 CAD | 910.2萬 CAD | 838.1萬 CAD |
| 毛利 | 900.77萬 CAD | 1354.8萬 CAD | 1205.3萬 CAD | 1156.3萬 CAD | 1098.3萬 CAD |
| 研究與開發 | 485.73萬 CAD | 494.3萬 CAD | 404.3萬 CAD | 1410.1萬 CAD | 766.3萬 CAD |
| 銷售、一般及管理費用 | 1885.83萬 CAD | 1903.3萬 CAD | 1913.5萬 CAD | 1899.1萬 CAD | 1805.5萬 CAD |
| 營業費用 | 2371.56萬 CAD | 2574.4萬 CAD | 2581.5萬 CAD | 3717.4萬 CAD | 2765.6萬 CAD |
| 利息收入 | — | — | 2.3萬 CAD | 12.2萬 CAD | 27.9萬 CAD |
| 利息支出 | — | 9914 CAD | 1.9萬 CAD | 3萬 CAD | 8.5萬 CAD |
| 折舊和攤銷 | 157.94萬 CAD | 511.9萬 CAD | 573.5萬 CAD | 668.5萬 CAD | 376.9萬 CAD |
| 營業利益 | −1470.79萬 CAD | −1219.6萬 CAD | −1376.2萬 CAD | −2561.1萬 CAD | −1667.3萬 CAD |
| 淨利 | −1373.51萬 CAD | −3023.4萬 CAD | −2611.5萬 CAD | −2656萬 CAD | −1670.9萬 CAD |
公司資料更新於 2026年10月13日。
近期已公布業績
近期已公布業績
報告持有此股票曝險的交易所交易基金。
AI 生成內容及延遲市場資料僅供資訊與教育用途，不構成投資建議。
